Finance

Lists
Why is HRTX down 9.30%?
Dive Deeper
HRTX:NASDAQ
Heron Therapeutics Inc
$0.33
-9.30%
(-0.033) 1D
$0.36
+11.69% (+0.038)
Pre-market
Closed: Nov 12, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HRTX...
Open
$0.36
High
$0.36
Low
$0.32
Mkt. cap
61.89M
Avg. vol.
6.98M
Volume
17.27K
52-wk high
$1.58
52-wk low
$0.26
EPS
-$0.19
Beta
1.66
Shares outstanding
190.27M
No. of employees
128
Open
$0.36
High
$0.36
Low
$0.32
Mkt. cap
61.89M
Avg. vol.
6.98M
Volume
17.27K
52-wk high
$1.58
52-wk low
$0.26
EPS
-$0.19
Beta
1.66
Shares outstanding
190.27M
No. of employees
128
News stories
From web sources and news partners
About Heron Therapeutics Inc
CEO-
Employees128
Founded1983
HeadquartersSan Diego, California, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 1 analyst giving stock ratings to HRTX in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for HRTX in the last 3 months
Highest
Current $0.33
(-100.00%)
Average
(-100.00%)
Lowest
(-100.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Hold
Maintained
-
-
11/11/2026
Serge Belanger
Needham
Hold
Maintained
-
-
08/10/2026
Carl Byrnes
Northland Securities
Buy
Reiterated
$4.00
+1,127.4%
11/05/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
40.59M
34.71M
37.67M
35.25M
Cost of goods sold
14.86M
13.02M
14.27M
12.06M
Cost of revenue
14.86M
13.02M
14.27M
12.06M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.68M
26.45M
25.44M
24.86M
Operating expense
25.68M
26.45M
25.44M
24.86M
Total operating expenses
40.55M
39.48M
39.71M
36.92M
Operating income
38.00K
-4.76M
-2.04M
-1.67M
Other non operating income
-821.00K
-146.00K
355.00K
263.00K
EBT including unusual items
-2.95M
-8.11M
-5.49M
-5.01M
EBT excluding unusual items
-2.54M
-8.11M
-5.49M
-5.01M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.95M
-8.11M
-5.49M
-5.01M
Net profit margin
-7.28%
-23.37%
-14.57%
-14.20%
Earnings per share
-0.02
-0.04
-0.03
-0.03
Interest and investment income
1.95M
-
-
-
Interest expense
-3.70M
-3.20M
-3.80M
-3.60M
Net interest expenses
-1.76M
-3.20M
-3.80M
-3.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
575.00K
-4.24M
-1.59M
-1.28M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps